Clinical Trials Browser

Phase 1/2 × Peripheral Nervous System Diseases × Acetylcysteine × Clear all

NCT03492047 2020-02-27

N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients

Phase 1/2 Completed

Peripheral Nervous System Diseases